CNOOC Limited (600938)
Shanghai Stock Exchange · China · prices in CNY · close of 22 Oct 2026
Key indicators
| Last close | CNY 33.80 |
|---|---|
| 52-week range | 26.18 – 44.54 |
| Return, 1 month / 3 months | +4.6% / +6.9% |
| Return, 1 year / 3 years | +29.8% / +91.5% |
| Trend | Uptrend |
| RSI (14) | 52 |
| Volatility (1 year) | 38.8% |
| Worst drawdown (1 year) | -38.4% |
| Average daily value traded | 1,581.05M CNY |
| Dividend yield | 3.8% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
CNOOC Limited is an oil and gas exploration and production company focused on offshore resources. It explores for, develops and produces crude oil and natural gas, chiefly in the waters off China such as the Bohai Bay, the South China Sea and the East China Sea, and it also holds interests in overseas oil and gas projects. Its customers are mainly refiners, energy traders and industrial buyers of crude oil and natural gas. The company is based in Hong Kong and belongs to the CNOOC group.
On this site CNOOC Limited appears as a stock on the Shanghai Stock Exchange (China), code 600938, with prices in Chinese yuan (CNY). Our dividend records, which start in 2019, show payments in 5 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
CNOOC Limited (600938) trades on the Shanghai Stock Exchange in China. It last closed at CNY 33.80 on 22 October 2026.
Its price-based Market X-Ray is 79 out of 100 (a strong price profile), ranking 80 of 2,278 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 29.8% and over the last three months it rose 6.9%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Shanghai Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 84 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 2.3% | ||
| From 52-week high | -22.1% | ||
| Momentum | 77 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | 6.9% | ||
| 6-month return | -5.1% | ||
| 12-month return, skipping the last month | 24.1% | ||
| Stability (higher is calmer) | 65 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 38.8% | ||
| Worst drawdown, 1 year (smaller is calmer) | -38.4% | ||
| Liquidity | 95 · Strong | Trades actively. | |
| Average daily value traded | 1,581.05M CNY | ||
| Zero-volume days | 0.0% | ||
| Income | 80 · Strong | Dividend is high and has been paid regularly. | |
| Dividend yield | 3.8% | ||
| Years with dividends | 5 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Momentum: Rising faster than most stocks on this exchange.
- Liquidity: Trades actively.
- Income: Dividend is high and has been paid regularly.
Weak spots
No lens is weak against its exchange.
Returns
| 1 week | −0.5% |
|---|---|
| 1 month | +4.6% |
| 3 months | +6.9% |
| 6 months | −5.1% |
| 1 year | +29.8% |
| 3 years | +91.5% |
| 5 years | – |
Signals
| 50-day / 200-day average | 32.90 / 33.03 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 1.04 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 16 Oct 2026 | CNY 0.8132 |
| 10 Jul 2026 | CNY 0.4788 |
| 17 Oct 2025 | CNY 0.6661 |
| 11 Jul 2025 | CNY 0.6051 |
| 18 Oct 2024 | CNY 0.6765 |
| 12 Jul 2024 | CNY 0.6004 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Shanghai Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.